These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38928345)

  • 21. Current view from Alzheimer disease to type 2 diabetes mellitus.
    Rasool M; Malik A; Qazi AM; Sheikh IA; Manan A; Shaheen S; Qazi MH; Chaudhary AG; Abuzenadah AM; Asif M; Alqahtani MH; Iqbal Z; Shaik MM; Gan SH; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):533-42. PubMed ID: 24059295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
    Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
    CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
    Luchsinger JA; Zetterberg H
    Int Rev Neurobiol; 2020; 154():51-77. PubMed ID: 32739014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival.
    Jude JG; Spencer GJ; Huang X; Somerville TDD; Jones DR; Divecha N; Somervaille TCP
    Oncogene; 2015 Mar; 34(10):1253-1262. PubMed ID: 24681948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cdk5-mediated oligodendrocyte myelin breakdown and neuroinflammation: Implications for the link between Type 2 Diabetes and Alzheimer's disease.
    Paul S; Bhardwaj J; Binukumar BK
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166986. PubMed ID: 38092158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer's disease.
    Lau SF; Cao H; Fu AKY; Ip NY
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25800-25809. PubMed ID: 32989152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Interplay between Diabetes and Alzheimer's Disease-In the Hunt for Biomarkers.
    Kubis-Kubiak A; Dyba A; Piwowar A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of molecular signatures and pathways shared by Alzheimer's disease and type 2 diabetes.
    Shu J; Li N; Wei W; Zhang L
    Gene; 2022 Feb; 810():146070. PubMed ID: 34813915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
    Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.
    Lei M; Teo JD; Song H; McEwen HP; Yup Lee J; Couttas TA; Duncan T; Chesworth R; Bertz J; Przybyla M; Van Eersel J; Heng B; Guillemin GJ; Ittner LM; Fath T; Garner B; Ittner A; Karl T; Don AS
    J Neurosci; 2019 Nov; 39(48):9645-9659. PubMed ID: 31641049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common cellular and molecular mechanisms underlying Alzheimer's disease and type 2 diabetes: a knowledge-driven approach.
    Gauthaman K; Pushparaj PN; Rajeshkumar M; Narasimhan K; Al-Qahtani M; Cheung NS; Manikandan J
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):247-58. PubMed ID: 24059321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity Genes of Alzheimer's Disease and Type 2 Diabetes Associated with Memory and Cognitive Function.
    Cho SB
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.
    Yokoyama JS; Wang Y; Schork AJ; Thompson WK; Karch CM; Cruchaga C; McEvoy LK; Witoelar A; Chen CH; Holland D; Brewer JB; Franke A; Dillon WP; Wilson DM; Mukherjee P; Hess CP; Miller Z; Bonham LW; Shen J; Rabinovici GD; Rosen HJ; Miller BL; Hyman BT; Schellenberg GD; Karlsen TH; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2016 Jun; 73(6):691-7. PubMed ID: 27088644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.
    Morabito S; Miyoshi E; Michael N; Shahin S; Martini AC; Head E; Silva J; Leavy K; Perez-Rosendahl M; Swarup V
    Nat Genet; 2021 Aug; 53(8):1143-1155. PubMed ID: 34239132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance.
    Vacínová G; Vejražková D; Lukášová P; Lischková O; Dvořáková K; Rusina R; Holmerová I; Vaňková H; Včelák J; Bendlová B; Vaňková M
    Mol Biol Rep; 2017 Apr; 44(2):227-231. PubMed ID: 28316001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of MEDAG as a Hub Candidate Gene in the Onset and Progression of Type 2 Diabetes Mellitus by Comprehensive Bioinformatics Analysis.
    Yang J; Yu P
    Biomed Res Int; 2021; 2021():3947350. PubMed ID: 33728329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?
    Zhang Y; Song W
    Prog Neurobiol; 2017 Jun; 153():100-120. PubMed ID: 28274676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.